Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model.
Silva JM, Zupancic E, Vandermeulen G, Oliveira VG, Salgado A, Videira M, Gaspar M, Graca L, Préat V, Florindo HF. Silva JM, et al. Among authors: zupancic e. J Control Release. 2015 Jan 28;198:91-103. doi: 10.1016/j.jconrel.2014.11.033. Epub 2014 Dec 5. J Control Release. 2015. PMID: 25483429
DC Respond to Cognate T Cell Interaction in the Antigen-Challenged Lymph Node.
Curato C, Bernshtein B, Zupancič E, Dufner A, Jaitin D, Giladi A, David E, Chappell-Maor L, Leshkowitz D, Knobeloch KP, Amit I, Florindo HF, Jung S. Curato C, et al. Among authors: zupancic e. Front Immunol. 2019 Apr 25;10:863. doi: 10.3389/fimmu.2019.00863. eCollection 2019. Front Immunol. 2019. PMID: 31073301 Free PMC article.
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators.
Conniot J, Scomparin A, Peres C, Yeini E, Pozzi S, Matos AI, Kleiner R, Moura LIF, Zupančič E, Viana AS, Doron H, Gois PMP, Erez N, Jung S, Satchi-Fainaro R, Florindo HF. Conniot J, et al. Among authors: zupancic e. Nat Nanotechnol. 2019 Sep;14(9):891-901. doi: 10.1038/s41565-019-0512-0. Epub 2019 Aug 5. Nat Nanotechnol. 2019. PMID: 31384037
Regulatory aspects on nanomedicines.
Sainz V, Conniot J, Matos AI, Peres C, Zupancic E, Moura L, Silva LC, Florindo HF, Gaspar RS. Sainz V, et al. Among authors: zupancic e. Biochem Biophys Res Commun. 2015 Dec 18;468(3):504-10. doi: 10.1016/j.bbrc.2015.08.023. Epub 2015 Aug 8. Biochem Biophys Res Commun. 2015. PMID: 26260323 Review.
15 results